Skip to main content

US ClosedU.S. Closed

TNGX: Tango Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments.

52W Range

59thpctl

Volume

0.55×avg

Market Cap

3.76BUSD

P/E Ratio

-27.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Tango Therapeutics, Inc.

TNGXNASDAQ Global Market·USD·Closed

Tango Therapeutics, Inc.

TNGXNASDAQ·USD·Closed

$23.08

−0.69%

$23.08

−$0.16 (0.69%)

52W Range

59thpctl

Volume

0.55×avg

Mkt Cap

3.76BUSD

P/E

-27.2TTM

Div Yield

–ann